adrenergic bronchodilator

adrenergic bronchodilator

a drug that acts on the beta-2 sympathetic nervous system of the receptors to relax bronchial smooth muscle cells. Examples include drugs that contain epINEPHrine, epHEDrine, isoproterenol hydrochloride, or albuterol.

Adrenergic Bronchodilator

An often aerosolised drug used to dilate bronchial lumina and reduce airway resistance in patients with asthma and chronic bronchitis.
Examples Adrenaline (epinephrine), albuterol (Proventil, Ventolin), arformoterol, bitolterol (Tornolate), ephedrine, epinephrine (adrenaline), formoterol (Perforomist), isoetharine, isoproterenol, levalbuterol, metaproterenol, pirbuterol (Maxair), racepinephrine, ritodrine, salmeterol, terbutaline (Brethine), theophylline.
Adverse effects Dyspnoea, tachypnoea, apnoea, hypertension, tachycardia, convulsions, coma, fever, tremor, cyanosis, nausea, vomiting, blurred vision.

adrenergic bronchodilator

Pharmacology An agent that dilates bronchial lumina and ↓ airway resistance, used for asthmatic Pts. See Asthma, Wheezing.
References in periodicals archive ?
Ipratropium is an anticholinergic bronchodilator, and albuterol is a selective beta 2 adrenergic bronchodilator.
The general indication for use of an adrenergic bronchodilator is relaxation of airway smooth muscle in the presence of reversible airflow obstruction associated with acute and chronic asthma (including exercise-induced asthma), bronchitis, emphysema, bronchiectasis, and other obstructive airway diseases.
It is a beta 2 adrenergic bronchodilator that causes relaxation of the smooth muscle of the bronchioles.
Cardiotoxicity of adrenergic bronchodilator and vasodilating antihypertensive drugs.
This article will review long acting adrenergic bronchodilator agents available and their indication for use.
The action of salmeterol in providing sustained protection from bronchoconstriction differs to a degree from that of the previously described adrenergic bronchodilators.
I will also discuss the benefits anticholingergic bronchodilators have when used in combination with adrenergic bronchodilators.
In the last two issues I had discussed the use of short and long acting adrenergic bronchodilators.
The most common clinically observed side effects of adrenergic bronchodilators are tremor, tachycardia, tolerance to bronchodilator effect, loss of bron-choprotection, nervousness, worsening ventilation to perfusion ratio, hypokalemia, and sensitivity to additives and propellants.
Commonly reported side effects of the adrenergic bronchodilators include headache, nervousness, irritability anxiety, and insomnia, which are caused by central nervous system stimulation.